SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-08-055463
Filing Date
2008-08-27
Accepted
2008-08-27 16:14:15
Documents
2
Period of Report
2008-08-23
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a08-22451_18k.htm 8-K 26096
2 EX-16.1 a08-22451_1ex16d1.htm EX-16.1 4146
  Complete submission text file 0001104659-08-055463.txt   31866
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21243 | Film No.: 081042228
SIC: 2835 In Vitro & In Vivo Diagnostic Substances